Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus corticosteroid injection for chronic lateral epicondylitis
NL-OMON30936Phase 4Active, not recruiting
- Sponsor
- Zimmer Biomet
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of platelet-rich plasma and lidocaine in Lateral Epicondylitis (LET) (2 arms), sponsored by Zimmer Biomet. Primary endpoints: Treatment success at each visit, Absolute change from baseline to endpoint in pain and 1 more. Started Jan 2008; status: active, not recruiting.
02
Drugs
platelet-rich plasmalidocaine
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NL-OMON30936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30936.